诺华制药(NVS) - 2023 Q2 - Quarterly Report

Novartis Second Quarter and Half Year 2023 Condensed Interim Financial Report – Supplementary Data INDEX Page GROUP AND DIVISIONAL OPERATING PERFORMANCE Group 3 Innovative Medicines 7 Sandoz 13 CASH FLOW AND GROUP BALANCE SHEET 15 INNOVATION REVIEW 18 CONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS Consolidated income statements 21 Consolidated statements of comprehensive income 23 Consolidated balance sheets 24 Consolidated statements of changes in equity 25 Consolidated statements of cash flows 27 Not ...